Skip links

PGT-A – Preimplantation Genetic Testing for Aneuploidies

PGT-A – Preimplantation Genetic Testing for Aneuploidies



A genetic test that screen embryos for chromosome abnormalities prior to transfer and improve success rate of in vitro fertilization (IVF) treatment.

Request Information


Embryos with abnormal chromosomes (also called aneuploid embryos) normally result in a miscarriage or may lead to the birth of a child with genetic condition.

PGT-A is particularly important for female patients over age 35, as the risk of chromosomal abnormality increases with maternal age.

PGT-A (also known as PGS, Preimplantation Genetic Screening) is a genetic testing before embryo transfer to screen the embryo genetic health, so that your physician could select the best embryo for implantation and achieving a successful pregnancy.

Moreover, PGT-A can greatly reduce the chances of a patient having multiple pregnancies by providing information to select the optimal embryo for Single Embryo Transfer.

This test is recommended for people who:

  • Women who are over the age of 35.
  • Couples with infertility concerns.
  • Couples with recurrent miscarriage.
  • Couples with three of more failed IVF cycles.
  • Couples with a family history of chromosomal abnormalities.
  • Couples undergoing IVF treatment for other reasons.

PGT-A can also synchronize with MIRA to increase the pregnancy rate: Maximizing the successful chances of best embryo transfer at the right time!

Find out more for MIRA test

Advantages of GGA PGT-A in Reproductive Medicine

Why Choose GGA PGT-A?



Download PDF

Related paper study

Click to study